Home ~ About us ~ Ahead of print ~ Current Issue ~ Back Issues ~ Search ~ Instructions ~ Subscription ~ Advertise ~ Feedback ~ Login  
  Mens Sana Monographs
A Monograph Series Devoted To The Understanding Of Medicine, Mental Health, Man, Mind, Music And Their Matrix
 Why MSM | Acknowledgement | Call for papers... | Forthcoming MSM...  Users online: 80  Home Email this article Print this Article Bookmark this page Decrease font size Default font size Increase font size 

 Table of Contents     
Year : 2016  |  Volume : 14  |  Issue : 1  |  Page : 240-260
Total Reference List MSM 2016

Date of Web Publication27-Oct-2016

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Neuromodulation, Emotional Feelings and Affective Disorders

Fushun Wang and Alfredo Pereira Jr. (p5-29)


  1. Almada LF, Pereira A Jr, Carrara-Augustenborg C. What affective neuroscience means for science of consciousness. Mens Sana Monogr 2013;11:253-73.
  2. Armbruster D, Mueller A, Strobel A, Kirschbaum C, Lesch KP, Brocke B. Influence of functional tryptophan hydroxylase 2 gene variation and sex on the startle response in children, young adults, and older adults. Biol Psychol 2010;83:214-21.
  3. Asan E, Steinke M, Lesch KP. Serotonergic innervation of the amygdala: Targets, receptors, and implications for stress and anxiety. Histochem Cell Biol 2013;139:785-813.
  4. Avena NM, Rada P, Moise N, Hoebel BG. Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience 2006;139:813-20.
  5. Avery MC, Dutt N, Krichmar JL. A large-scale neural network model of the influence of neuromodulatory levels on working memory and behavior. Front Comput Neurosci 2013;7:133.
  6. Azmitia EC, Liao B, Chen YS. Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J Neurosci 1993;13:5041-55.
  7. Boadle-Biber MC, Corley KC, Graves L, Phan TH, Rosecrans J. Increase in the activity of tryptophan hydroxylase from cortex and midbrain of male Fischer 344 rats in response to acute or repeated sound stress. Brain Res 1989;482:306-16.
  8. Bos MG, Jentgens P, Beckers T, Kindt M. Psychophysiological response patterns to affective film stimuli. PLoS One 2013;8:e62661.
  9. Bozarth MA, Gerber GJ, Wise RA. Intracranial self-stimulation as a technique to study the reward properties of drugs of abuse. Pharmacol Biochem Behav 1980;13 Suppl 1:245-7.
  10. Bozarth MA, Wise RA. Electrolytic microinfusion transducer system: An alternative method of intracranial drug application. J Neurosci Methods 1980;2:273-5.
  11. Bremner JD, Krystal JH, Southwick SM, Charney DS. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 1996;23:28-38.
  12. Bremner JD, Krystal JH, Southwick SM, Charney DS. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 1996;23:39-51.
  13. Cabib S, Puglisi-Allegra S. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J Neurosci 1994;14:3333-40.
  14. Carlborg A, Jokinen J, Nordström AL, Jönsson EG, Nordström P. CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis. Schizophr Res 2009;112:80-5.
  15. Chau DT, Rada PV, Kim K, Kosloff RA, Hoebel BG. Fluoxetine alleviates behavioral depression while decreasing acetylcholine release in the nucleus accumbens shell. Neuropsychopharmacology 2011;36:1729-37.
  16. Cohen LJ, Sclar DA. Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure. J Clin Psychiatry 2012;73 Suppl 1:31-6.
  17. Curró Dossi R, Paré D, Steriade M. Short-lasting nicotinic and long-lasting muscarinic depolarizing responses of thalamocortical neurons to stimulation of mesopontine cholinergic nuclei. J Neurophysiol 1991;65:393-406.
  18. Dai JX, Han HL, Tian M, Cao J, Xiu JB, Song NN, et al. Enhanced contextual fear memory in central serotonin-deficient mice. Proc Natl Acad Sci U S A 2008;105:11981-6.
  19. Damasio A. The Feeling of What Happens: Body, Emotion and the Making of Consciousness. London: Vintage; 1999.
  20. Dani JA, Harris RA. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 2005;8:1465-70.
  21. Delgado MR, Gillis MM, Phelps EA. Regulating the expectation of reward via cognitive strategies. Nat Neurosci 2008;11:880-1.
  22. Dempsey JP, Randall PK, Thomas SE, Book SW, Carrigan MH. Treatment of social anxiety with paroxetine: Mediation of changes in anxiety and depression symptoms. Compr Psychiatry 2009;50:135-41.
  23. Devilbiss DM, Waterhouse BD, Berridge CW, Valentino R. Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses. Neuropsychopharmacology 2012;37:2020-30.
  24. Diana M. The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry 2011;2:64.
  25. Dilsaver SC, Alessi NE. Chronic inescapable footshock produces cholinergic system supersensitivity. Biol Psychiatry 1987;22:914-8.
  26. Eggermann E, Feldmeyer D. Cholinergic filtering in the recurrent excitatory microcircuit of cortical layer 4. Proc Natl Acad Sci U S A 2009;106:11753-8.
  27. Ekman P. Emotions inside out 130 Years after Darwin's "The expression of the emotions in man and animal". Ann N Y Acad Sci 2003;1000:1-6.
  28. Engström G, Alling C, Blennow K, Regnéll G, Träskman-Bendz L. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol 1999;9:399-405.
  29. Fakra E, Azorin JM, Adida M, Da Fonseca D, Kaladjian A, Pringuey D. [Affective disorders and antidepressant drugs: Therapeutic innovations]. Encephale 2010;36 Suppl 6:S183-7.
  30. Fernandez SP, Gaspar P. Investigating anxiety and depressive-like phenotypes in genetic mouse models of serotonin depletion. Neuropharmacology 2012;62:144-54.
  31. Fukui M, Rodriguiz RM, Zhou J, Jiang SX, Phillips LE, Caron MG, et al. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci 2007;27:10520-9.
  32. Gardenfors P. Conceptual Spaces: The Geometry of Thought. Cambridge: MIT Press; 2000.
  33. George SA, Knox D, Curtis AL, Aldridge JW, Valentino RJ, Liberzon I. Altered locus coeruleus-norepinephrine function following single prolonged stress. Eur J Neurosci 2013;37:901-9.
  34. Goel N, Workman JL, Lee TT, Innala L, Viau V. Sex differences in the HPA axis. Compr Physiol 2014;4:1121-55.
  35. Graeff FG, Silveira MC, Nogueira RL, Audi EA, Oliveira RM. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav Brain Res 1993;58:123-31.
  36. Gruber J, Dutra S, Eidelman P, Johnson SL, Harvey AG. Emotional and physiological responses to normative and idiographic positive stimuli in bipolar disorder. J Affect Disord 2011;133:437-42.
  37. Gulledge AT, Park SB, Kawaguchi Y, Stuart GJ. Heterogeneity of phasic cholinergic signaling in neocortical neurons. J Neurophysiol 2007;97:2215-29.
  38. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003;37:233-47.
  39. Higley JD, Mehlman PT, Poland RE, Taub DM, Vickers J, Suomi SJ, et al. CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry 1996;40:1067-82.
  40. Hoebel BG, Avena NM, Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol 2007;7:617-27.
  41. Holmes A, Murphy DL, Crawley JN. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 2002;161:160-7.
  42. Houdé O, Zago L, Crivello F, Moutier S, Pineau A, Mazoyer B, et al. Access to deductive logic depends on a right ventromedial prefrontal area devoted to emotion and feeling: Evidence from a training paradigm. Neuroimage 2001;14:1486-92.
  43. Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, et al. Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter. J Med Chem 2002;45:4097-109.
  44. Inoue T, Inokuma Y, Watanabe S, Kirino Y. In vitro study of odor-evoked behavior in a terrestrial mollusk. J Neurophysiol 2004;91:372-81.
  45. Itoi K. Ablation of the central noradrenergic neurons for unraveling their roles in stress and anxiety. Ann N Y Acad Sci 2008;1129:47-54.
  46. Itoi K, Sugimoto N. The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol 2010;22:355-61.
  47. Jack RE, Caldara R, Schyns PG. Internal representations reveal cultural diversity in expectations of facial expressions of emotion. J Exp Psychol Gen 2012;141:19-25.
  48. Jacobs BL. Serotonin and behavior: Emphasis on motor control. J Clin Psychiatry 1991;52 Suppl:17-23.
  49. Jacobs BL, Fornal CA. Activity of brain serotonergic neurons in the behaving animal. Pharmacol Rev 1991;43:563-78.
  50. Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972;2:632-5.
  51. Janowsky DS, el-Yousef MK, Davis JM. Acetylcholine and depression. Psychosom Med 1974;36:248-57.
  52. Janowsky DS. Serendipity strikes again: Scopolamine as an antidepressant agent in bipolar depressed patients. Curr Psychiatry Rep 2011;13:443-5.
  53. Jokinen J, Nordström AL, Nordström P. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters. Arch Suicide Res 2007;11:187-92.
  54. Kobayashi T, Hayashi E, Shimamura M, Kinoshita M, Murphy NP. Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: A comparative and correlational study. Psychopharmacology (Berl) 2008;197:567-80.
  55. LeDoux J. The Emotional Brain: The Mysterous Underpinnings of Emotional Life. New York: Simon & Schuster; 1996.
  56. LeDoux J. Fear and the brain: Where have we been, and where are we going? Biol Psychiatry 1998;44:1229-38.
  57. LeMarquand DG, Pihl RO, Young SN, Tremblay RE, Séguin JR, Palmour RM, et al. Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males. Neuropsychopharmacology 1998;19:333-41.
  58. Levine ES, Litto WJ, Jacobs BL. Activity of cat locus coeruleus noradrenergic neurons during the defense reaction. Brain Res 1990;531:189-95.
  59. Lidberg L, Tuck JR, Asberg M, Scalia-Tomba GP, Bertilsson L. Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 1985;71:230-6.
  60. Ling TJ, Forster GL, Watt MJ, Korzan WJ, Renner KJ, Summers CH. Social status differentiates rapid neuroendocrine responses to restraint stress. Physiol Behav 2009;96:218-32.
  61. Lipp I, Murphy K, Wise RG, Caseras X. Understanding the contribution of neural and physiological signal variation to the low repeatability of emotion-induced BOLD responses. Neuroimage 2014;86:335-42.
  62. Martin P, Gozlan H, Puech AJ. 5-HT3 receptor antagonists reverse helpless behaviour in rats. Eur J Pharmacol 1992;212:73-8.
  63. Maslow AH. A theory of human motivation. Psychol Rev 1943;50:370-96.
  64. Maswood S, Barter JE, Watkins LR, Maier SF. Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. Brain Res 1998;783:115-20.
  65. McGaugh JL, Cahill L. Interaction of neuromodulatory systems in modulating memory storage. Behav Brain Res 1997;83:31-8.
  66. Mearns J, Dunn J, Lees-Haley PR. Psychological effects of organophosphate pesticides: A review and call for research by psychologists. J Clin Psychol 1994;50:286-94.
  67. Miller LA. Impulsivity, risk-taking, and the ability to synthesize fragmented information after frontal lobectomy. Neuropsychologia 1992;30:69-79.
  68. Moberg T, Nordström P, Forslund K, Kristiansson M, Asberg M, Jokinen J. CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters. J Affect Disord 2011;132:173-8.
  69. Monti JM. Serotonin control of sleep-wake behavior. Sleep Med Rev 2011;15:269-81.
  70. Mora F, Ferrer JM. Neurotransmitters, pathways and circuits as the neural substrates of self-stimulation of the prefrontal cortex: Facts and speculations. Behav Brain Res 1986;22:127-40.
  71. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, et al. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1214-24.
  72. Narboux-Nême N, Sagné C, Doly S, Diaz SL, Martin CB, Angenard G, et al. Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: Neural and behavioral consequences. Neuropsychopharmacology 2011;36:2538-50.
  73. Overstreet DH. The Flinders sensitive line rats: A genetic animal model of depression. Neurosci Biobehav Rev 1993;17:51-68.
  74. Packard MG, Cahill L, McGaugh JL. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes. Proc Natl Acad Sci U S A 1994;91:8477-81.
  75. Pakalnis A, Splaingard M, Splaingard D, Kring D, Colvin A. Serotonin effects on sleep and emotional disorders in adolescent migraine. Headache 2009;49:1486-92.
  76. Palumbo L, Jellema T. Beyond face value: Does involuntary emotional anticipation shape the perception of dynamic facial expressions? PLoS One 2013;8:e56003.
  77. Panksepp J. Affective Neuroscience: The Foundations of Human and Animal Emotions. Oxford: Oxford University Press; 1998.
  78. Pereira A Jr. Triple-Aspect Monism: A Framework for the Science of Human Consciousness. Cambridge, UK: Cambridge University Press; 2013.
  79. Petty F, Kramer G, Moeller M. Does learned helplessness induction by haloperidol involve serotonin mediation? Pharmacol Biochem Behav 1994;48:671-6.
  80. Petty F, Kramer G, Wilson L, Jordan S. In vivo serotonin release and learned helplessness. Psychiatry Res 1994;52:285-93.
  81. Philip NS, Carpenter LL, Tyrka AR, Price LH. Nicotinic acetylcholine receptors and depression: A review of the preclinical and clinical literature. Psychopharmacology (Berl) 2010;212:1-12.
  82. Plutchik R. The Emotions: Facts, Theories, and a New Model. New York: Random House; 1962.
  83. Rada PV, Mark GP, Hoebel BG. Dopamine release in the nucleus accumbens by hypothalamic stimulation-escape behavior. Brain Res 1998;782:228-34.
  84. Rasmussen K, Morilak DA, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res 1986;371:324-34.
  85. Redgrave P, Prescott TJ, Gurney K. Is the short-latency dopamine response too short to signal reward error? Trends Neurosci 1999;22:146-51.
  86. Rocha AF. The brain: a brief report of its function. Jundiaí (Brasil): EINA; 1999.
  87. Ron D, Jurd R. The "ups and downs" of signaling cascades in addiction. Sci STKE 2005;2005:re14.
  88. Roy A, Lamparski D, De Jong J, Adinoff B, Ravitz B, George DT, et al. Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatr Scand 1990;81:58-61.
  89. Russell JA. Core affect and the psychological construction of emotion. Psychol Rev 2003;110:145-72.
  90. Samson RD, Frank MJ, Fellous JM. Computational models of reinforcement learning: The role of dopamine as a reward signal. Cogn Neurodyn 2010;4:91-105.
  91. Šaponjic J. Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms. Glas Srp Akad Nauka Med 2011;51:85-97.
  92. Sara SJ, Bouret S. Orienting and reorienting: The locus coeruleus mediates cognition through arousal. Neuron 2012;76:130-41.
  93. Sauter DA, Eisner F, Calder AJ, Scott SK. Perceptual cues in nonverbal vocal expressions of emotion. Q J Exp Psychol (Hove) 2010;63:2251-72.
  94. Savelieva KV, Zhao S, Pogorelov VM, Rajan I, Yang Q, Cullinan E, et al. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 2008;3:e3301.
  95. Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science 1967;156:21-37.
  96. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997;275:1593-9.
  97. Shumake J, Ilango A, Scheich H, Wetzel W, Ohl FW. Differential neuromodulation of acquisition and retrieval of avoidance learning by the lateral habenula and ventral tegmental area. J Neurosci 2010;30:5876-83.
  98. Siegel A, Bhatt S, Bhatt R, Zalcman SS. The neurobiological bases for development of pharmacological treatments of aggressive disorders. Curr Neuropharmacol 2007;5:135-47.
  99. Singh VB, Onaivi ES, Phan TH, Boadle-Biber MC. The increases in rat cortical and midbrain tryptophan hydroxylase activity in response to acute or repeated sound stress are blocked by bilateral lesions to the central nucleus of the amygdala. Brain Res 1990;530:49-53.
  100. Terry EL, DelVentura JL, Bartley EJ, Vincent AL, Rhudy JL. Emotional modulation of pain and spinal nociception in persons with major depressive disorder (MDD). Pain 2013;154:2759-68.
  101. Timotijevic I, Stankovic Ž, Todorovic M, Markovic SZ, Kastratovic DA. Serotonergic organization of the central nervous system. Psychiatr Danub 2012;24 Suppl 3:S326-30.
  102. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry 1987;44:241-7.
  103. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997;386:827-30.
  104. Volkow ND, Wang GJ, Fowler JS. Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann N Y Acad Sci 1997;820:41-54.
  105. Wheeler DC, Morgan R, Thomas DM, Seed M, Rees A, Moore RH. Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients. Transpl Int 1996;9:221-6.
  106. Willuhn I, Wanat MJ, Clark JJ, Phillips PE. Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci 2010;3:29-71.
  107. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005;45:11-6.

Neural Implications of Psychotherapy, Pharmacotherapy, and Combined Treatment in Major Depressive Disorder

Thomas L. Schwartz and Daniel Santarsieri (p30-45)


  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Revised Edition. Washington, DC: American Psychiatric Press; 2013.
  2. Baxter LR Jr., Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:681-9.
  3. Brody AL, Barsom MW, Bota RG, Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin Clin Neuropsychiatry 2001;6:102-12.
  4. Crocker LD, Heller W, Warren SL, O'Hare AJ, Infantolino ZP, Miller GA. Relationships among cognition, emotion, and motivation: Implications for intervention and neuroplasticity in psychopathology. Front Hum Neurosci 2013;7:261.
  5. de Jonghe F, Hendricksen M, van Aalst G, Kool S, Peen V, Van R, et al. Psychotherapy alone and combined with pharmacotherapy in the treatment of depression. Br J Psychiatry 2004;185:37-45.
  6. de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord 2001;64:217-29.
  7. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008;9:788-96.
  8. Dichter GS, Felder JN, Petty C, Bizzell J, Ernst M, Smoski MJ. The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry 2009;66:886-97.
  9. Forgeard MJ, Haigh EA, Beck AT, Davidson RJ, Henn FA, Maier SF, et al. Beyond depression: Towards a process-based approach to research, diagnosis, and treatment. Clin Psychol (New York) 2011;18:275-99.
  10. Frewen PA, Dozois DJ, Lanius RA. Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review. Clin Psychol Rev 2008;28:228-46.
  11. Friedman MA, Detweiler-Bedell JB, Leventhal HE, Home R, Keitner GI, Miller IW. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol 2006;11:47-68.
  12. Gabbard GO. A neurobiologically informed perspective on psychotherapy. Br J Psychiatry 2000;177:117-22.
  13. Gorwood P, Rouillon F, Even C, Falissard B, Corruble E, Moran P. Treatment response in major depression: Effects of personality dysfunction and prior depression. Br J Psychiatry 2010;196:139-42.
  14. Harley R, Sprich S, Safren S, Jacobo M, Fava M. Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression. J Nerv Ment Dis 2008;196:136-43.
  15. Henn FA, Edwards E, Anderson D, Vollmayr B. Psychotherapy and antidepressant treatment of depression: Evidence for similar neurobiological mechanisms. World Psychiatry 2002;1:115-7.
  16. Hollon SD, DeRubeis RJ, Fawcett J, Amsterdam JD, Shelton RC, Zajecka J, et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: A randomized clinical trial. JAMA Psychiatry 2014;71:1157-64.
  17. Jindal RD, Thase ME. Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders. Psychiatr Serv 2003;54:1484-90.
  18. Kandel ER. A new intellectual framework for psychiatry. Am J Psychiatry 1998;155:457-69.
  19. Katz MM, Bowden CL, Frazer A. Rethinking depression and the actions of antidepressants: Uncovering the links between the neural and behavioral elements. J Affect Disord 2010;120:16-23.
  20. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008;5:e45.
  21. Koch JM, Hinze-Selch D, Stingele K, Huchzermeier C, Goder R, Seeck-Hirschner M, et al. Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression. Psychother Psychosom 2009;78:187-92.
  22. Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, et al. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: The REVAMP Trial. Arch Gen Psychiatry 2009;66:1178-88.
  23. Kool S, Dekker J, Duijsens IJ, de Jonghe F, Puite B. Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders. Harv Rev Psychiatry 2003;11:133-41.
  24. Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, et al. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord 2009;117:174-9.
  25. Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J. Neurobiology of depression: An integrated view of key findings. Int J Clin Pract 2007;61:2030-40.
  26. McGrath CL, Kelley ME, Holtzheimer PE, Dunlop BW, Craighead WE, Franco AR, et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 2013;70:821-9.
  27. Moradveisi L, Huibers MJ, Renner F, Arasteh M, Arntz A. The influence of comorbid personality disorder on the effects of behavioural activation vs. antidepressant medication for major depressive disorder: Results from a randomized trial in Iran. Behav Res Ther 2013;51:499-506.
  28. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A 2003;100:14293-6.
  29. Nestler EJ. Epigenetic mechanisms in psychiatry. Biol Psychiatry 2009;65:189-90.
  30. Perroud N, Salzmann A, Prada P, Nicastro R, Hoeppli ME, Furrer S, et al. Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene. Transl Psychiatry 2013;3:e207.
  31. Peselow ED, Sanfilipo MP, Fieve RR, Gulbenkian G. Personality traits during depression and after clinical recovery. Br J Psychiatry 1994;164:349-54.
  32. Reich JH, Vasile RG. Effect of personality disorders on the treatment outcome of axis I conditions: An update. J Nerv Ment Dis 1993;181:475-84.
  33. Schwartz TL, Rashid A. Augmentation and combination pharmacotherapy trends in major depressive disorder: Results of a brief survey of psychiatrists. Pharm Ther 2007;32:28-31.
  34. Schwartz TL. Psychopharmacological practice: The DSM versus the brain. Mens Sana Monogr 2013;11:25-41.
  35. Stahl SM. The 7 habits of highly effective psychopharmacologists, part 3: Sharpen the saw with selective choices of continuing medical education programs. J Clin Psychiatry 2000;61:401-2.
  36. Stahl SM. Symptoms and circuits, part 1: Major depressive disorder. J Clin Psychiatry 2003;64:1282-3.
  37. Stahl SM. The last Diagnostic and Statistical Manual (DSM): Replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses. CNS Spectr 2013;18:65-8.
  38. Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Application. 4 th ed. Cambridge: Cambridge University Press; 2013.
  39. Stahl SM, Zhang L, Damatarca C, Grady M. Brain circuits determine destiny in depression: A novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J Clin Psychiatry 2003;64 Suppl 14:6-17.
  40. Sweatt JD. Experience-dependent epigenetic modifications in the central nervous system. Biol Psychiatry 2009;65:191-7.
  41. Takahashi M, Shirayama Y, Muneoka K, Suzuki M, Sato K, Hashimoto K. Personality traits as risk factors for treatment-resistant depression. PLoS One 2013;8:e63756.
  42. Thase ME. The role of Axis II comorbidity in the management of patients with treatment-resistant depression. Psychiatr Clin North Am 1996;19:287-309.
  43. Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. Am J Psychiatry 2007;164:739-52.
  44. Thase ME, Greenhouse JB, Frank E, Reynolds CF 3 rd , Pilkonis PA, Hurley K, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997;54:1009-15.
  45. Topel ME, Zajecka JM, Goldstein CN, Siddiqui UA, Schwartz TL. Using what we have: Combining medications to achieve remission. Clin Neuropsychiatry 2011;8:4-27.
  46. Wang F, Pereira A. Neuromodulation, emotional feelings, and affective disorders. Mens Sana Mongr 2016;14:5-29.
  47. Wilberg T, Friis S, Karterud S, Mehlum L, Urnes O, Vaglum P. Patterns of short-term course in patients treated in a day unit for personality disorders. Compr Psychiatry 1998;39:75-84.

Bioethical and Other Philosophical Considerations in Positive Psychiatry

Ajai R. Singh and Shakuntala A. Singh (p46-107)


  1. Al-Rodhan N. The many ethical implications of emerging technologies. Scientific American, March 13 2015. Available from: http://www.scientificamerican.com/article/the-many-ethical-implications-of-emerging-technologies. [Last accessed on 2016 Jan 10].
  2. American Psychiatric Association. The Principles of Medical Ethics with Annotations Especially Applicable to Psychiatry, 2013. Available from: https://www.psychiatry.org/psychiatrists/practice/ethics. [Last accessed on 2016 Jan 10].
  3. Baron J. The Reilly Center for Science Technology, and Values Releases 2015 List of Emerging Ethical Dilemmas and Policy Issues in Science and Technology. 08 December, 2014. The Reilly Center for Science Technology, and Values. Available from: http://www.reilly.nd.edu/news-and-events/news/54592-the-reilly-center-for-science-technology-and-values-releases-2015-list-of-emerging-ethical-dilemmas-and-policy-issues-in-science-and-technology. [Last accessed on 2016 Jan 10].
  4. Beauchamp TL. Making principlism practical. Bioethics 2011;25:301-3.
  5. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 6 th ed. New York: Oxford University Press; 2009.
  6. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 7 th ed. New York: Oxford University Press; 2013.
  7. Bech P. Clinical Psychometrics. Oxford: Wiley-Blackwell; 2012.
  8. Belmont Report. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: The Belmont Report Ethical Principles and Guidelines for the Protection of Human Subjects of Research. DHEW Publication No. (OS) 78-0012. Washington, DC: Superintendent of Documents, U.S. Government Printing Office; 1979. Available from: http://www.videocast.nih.gov/pdf/ohrp_belmont_report.pdf. [Last accessed on 2016 Jan 20].
  9. Birket-Smith M, Hansen BH, Hanash JA, Hansen JF, Rasmussen A. Mental disorders and general well-being in cardiology outpatients-6-year survival. J Psychosom Res 2009;67:5-10.
  10. Bloch S, Chodoff P, editors. Introduction. In: Psychiatric ethics. Oxford: OUP; 1984. p. 1-12.
  11. Carver CS, Scheier MF, Segerstrom SC. Optimism. Clin Psychol Rev 2010;30:879-89.
  12. Cloninger CR. The science of well-being: An integrated approach to mental health and its disorders. World Psychiatry 2006;5:71-6.
  13. Cloninger CR. Healthy personality development and well-being. World Psychiatry 2012;11:103-4.
  14. Cloninger CR. What makes people healthy, happy, and fulfilled in the face of current world challenges? Mens Sana Monogr 2013;11:16-24.
  15. Compton WC. An Introduction to Positive Psychology. 5 th ed. Wadsworth Publishing; 2014. p. 1-22.
  16. Compton WC, Hoffman E. Positive Psychology. The Science of Happiness and Flourishing. 2 nd ed. Belmont, CA: Wadsworth Cengage Learning; 2012.
  17. Diener E, Chan MY. Happy people live longer. Subjective well-being contributes to health and longevity. Appl Psychol Health Well Being 2011;3:1-43.
  18. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004;101:17312-5.
  19. Friedman HL, Robbins BD. The negative shadow cast by positive psychology. Contrasting views and implications of humanistic and positive psychology on resiliency. Humanist Psychol 2012;40:87-102.
  20. Fulford KW. Values-based practice. A new partner to evidence-based practice and a first for psychiatry? Mens Sana Monogr 2008;6:10-21.
  21. Fulford KW, Davies M, Gipps R, Graham G, Sadler J, Stanghellini G, et al., editors. Oxford Handbook of Philosophy and Psychiatry. Oxford: OUP; 2013.
  22. Clouser KD, Gert B. A critique of principlism. J Med Philos 1990;15:219-36.
  23. Giltay EJ, Geleijnse JM, Zitman FG, Buijsse B, Kromhout D. Lifestyle and dietary correlates of dispositional optimism in men: The Zutphen Elderly Study. J Psychosom Res 2007;63:483-90.
  24. Giltay EJ, Geleijnse JM, Zitman FG, Hoekstra T, Schouten EG. Dispositional optimism and all-cause and cardiovascular mortality in a prospective cohort of elderly dutch men and women. Arch Gen Psychiatry 2004;61:1126-35.
  25. Gordon JS. Global ethics and principlism. Kennedy Inst Ethics J 2011;21:251-76.
  26. Hackney CH, Sanders GS. Religiosity and mental health: A meta-analysis of recent studies. J Sci Study Religion 2003;42:43-55.
  27. Haidt J. The Happiness Hypothesis: Finding Modern Truth in Ancient Wisdom. New York: Basic Books; 2006.
  28. Hare RM. Moral Thinking: Its Levels, Method and Point. Oxford: OUP; 1981.
  29. Hare R. The philosophical basis of psychiatric practice. In: Bloch S, Chodoff P, editors. Psychiatric Ethics. Oxford: OUP; 1984. p. 30-45.
  30. Harmell AL, Mausbach BT, Roepke SK, Moore RC, von Kanel R, Patterson TL, et al. The relationship between self-efficacy and resting blood pressure in spousal Alzheimer's caregivers. Br J Health Psychol 2011;16:317-28.
  31. Henkel V, Mergl R, Kohnen R, Maier W, Möller HJ, Hegerl U. Identifying depression in primary care: A comparison of different methods in a prospective cohort study. BMJ 2003;326:200-1.
  32. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: A meta-analytic review. PLoS Med 2010;7:e1000316.
  33. Ikeda A, Schwartz J, Peters JL, Fang S, Spiro A 3 rd , Sparrow D, et al. Optimism in relation to inflammation and endothelial dysfunction in older men: The VA Normative Aging Study. Psychosom Med 2011;73:664-71.
  34. Jeste DV. Positive psychiatry. Psychiatr News 2012;47:4. Available from: http://www.psychnews.psychiatryonline.org/doi/full/10.1176%2Fpn.47.12.psychnews_47_12_4-a. [Last accessed on 216 Jan 18].
  35. Jeste DV. A fulfilling year of APA presidency: From DSM-5 to positive psychiatry. Am J Psychiatry 2013;170:1102-5.
  36. Jeste DV, Harris JC. Wisdom - a neuroscience perspective. JAMA 2010;304:1602-3.
  37. Jeste DV, Palmer BW. Positive Psychiatry: A Clinical Handbook. Washington: American Psychiatric Publishing; 2015. p. 2-3.
  38. Kahneman D. Well-Being: The Foundations of Hedonic Psychology. New York: Russell Sage Foundation; 2003.
  39. Kant I. Grundlegung zur Metaphysik der Sitten (Groundwork for the Metaphysics of Morals, 1785). Akademie-Ausgabe Kant Werke IV. Berlin: Walter de Gruyter; 1968.
  40. Karlsson H. Problems in the definitions of positive mental health. World Psychiatry 2012;11:106-7.
  41. Koenig HG. Concerns about measuring "spirituality" in research. J Nerv Ment Dis 2008;196:349-55.
  42. Koenig HG, McCullough ME, Larson DB: Handbook of Religion and Health. OUP; 2001.
  43. Lahdenperä M, Lummaa V, Helle S, Tremblay M, Russell AF. Fitness benefits of prolonged post-reproductive lifespan in women. Nature 2004;428:178-81.
  44. Lamond AJ, Depp CA, Allison M, Langer R, Reichstadt J, Moore DJ, et al. Measurement and predictors of resilience among community-dwelling older women. J Psychiatr Res 2008;43:148-54.
  45. Lief A, editor. The Commonsense Psychiatry of Dr. Adolf Meyer. New York: McGraw-Hill; 1948.
  46. Lewinsohn PM, Graf M. Pleasant activities and depression. J Consult Clin Psychol 1973;41:261-8.
  47. Lewinsohn PM, Libet J. Pleasant events, activity schedules, and depressions. J Abnorm Psychol 1972;79:291-5.
  48. Linden M. What is health and what is positive? The ICF solution. World Psychiatry 2012;11:104-5.
  49. Linley PA, Joseph S, Harrington S, Wood AM. Positive psychology: Past, present, and (possible) future. J Posit Psychol 2006;1:3-16.
  50. Lolas F. Bioethics and psychiatry: A challenging future. World Psychiatry 2002;1:123-4.
  51. Mausbach BT, Patterson TL, Von Känel R, Mills PJ, Dimsdale JE, Ancoli-Israel S, et al. The attenuating effect of personal mastery on the relations between stress and Alzheimer caregiver health: A five-year longitudinal analysis. Aging Ment Health 2007;11:637-44.
  52. Mausbach BT, Coon DW, Patterson TL, Grant I. Engagement in activities is associated with affective arousal in Alzheimer's caregivers: A preliminary examination of the temporal relations between activity and affect. Behav Ther 2008;39:366-74.
  53. Mausbach BT, von Känel R, Patterson TL, Dimsdale JE, Depp CA, Aschbacher K, et al. The moderating effect of personal mastery and the relations between stress and Plasminogen Activator Inhibitor-1 (PAI-1) antigen. Health Psychol 2008;27 2 Suppl: S172-9.
  54. Mausbach BT, Harmell AL, Moore RC, Chattillion EA. Influence of caregiver burden on the association between daily fluctuations in pleasant activities and mood: A daily diary analysis. Behav Res Ther 2011;49:74-9.
  55. Mausbach BT, Chattillion E, Roepke SK, Ziegler MG, Milic M, von Känel R, et al. A longitudinal analysis of the relations among stress, depressive symptoms, leisure satisfaction, and endothelial function in caregivers. Health Psychol 2012;31:433-40.
  56. Metz T. New developments in the meaning of life. Philos Compass 2007;2:196-217.
  57. McKeon RM, editor. The Basic works of Aristotle. New York: Modern Library; 2001.
  58. Moore RC, Eyler LT, Mills PJ, O'Hara RM, Wachnann K, Lavretsky H. Biology of positive psychiatry. In: Jeste DV, Palmer BW, editors. Positive Psychiatry: A Clinical Handbook. Washington: American Psychiatric Publishing; 2015.
  59. Papanas N, Tsapas A, Papatheodorou K, Papazoglou D, Bekiari E, Sariganni M, et al. Glycaemic control is correlated with well-being index (WHO-5) in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes 2010;118:364-7.
  60. Pellegrino E, Thomasma D. For the Patient's Good: The Restoration of Beneficence in Health Care. New York: Oxford University Press; 1988.
  61. Psychiatric Research Unit. WHO Collaborating Centre in Mental Health: WHO (Five) Well-Being Index (1998 version). Available from: http://www.psykiatri-regionh.dk/NR/rdonlyres/ACF049D6-C94D-49B2-B34C-96A7C5DA463B/0/WHO5_English.pdf. [Last accessed on 2016 Jan 20].
  62. Randall F. Ethical issues in cancer pain management. In: Sykes N, Bennett MI, Yuan CS, editors. Clinical Pain Management: Cancer Pain. 2 nd ed. London: Hodder Arnold; 2008. p. 93-100.
  63. Rasmussen HN, Scheier MF, Greenhouse JB. Optimism and physical health: A meta-analytic review. Ann Behav Med 2009;37:239-56.
  64. Rius-Ottenheim N, Kromhout D, van der Mast RC, Zitman FG, Geleijnse JM, Giltay EJ. Dispositional optimism and loneliness in older men. Int J Geriatr Psychiatry 2012;27:151-9.
  65. Salander P. Who needs the concept of "spirituality"? Psycho-Oncology 2006;15:647-9.
  66. Schneider PL, Bramstedt KA. When psychiatry and bioethics disagree about patient decision making capacity (DMC). J Med Ethics 2006;32:90-3.
  67. Seeman TE, Dubin LF, Seeman M. Religiosity/spirituality and health. A critical review of the evidence for biological pathways. Am Psychol 2003;58:53-63.
  68. Seligman MEP. The president's address (annual report). Am Psychol 1999;54:559-62.
  69. Seligman MEP. Learned Optimism: How to Change Your Mind and Your Life. 6 th ed. New York: Pocket Books; 2006.
  70. Seligman MEP, Csikszentmihalyi M. Positive psychology. An introduction. Am Psychol 2000;55:5-14.
  71. Singh AR. The bioethics of positive psychiatry. In: Jeste DV, Palmer BW, editors. Positive Psychiatry: A Clinical Handbook. Washington: American Psychiatric Publishing; 2015. p. 325-46.
  72. Singh AR, Singh SA. Psychiatric ethics: Role of philosophical enquiry. Indian Philos Q 1989;xvi:89-118.
  73. Singh A, Singh S. To cure sometimes, to comfort always, to hurt the least, to harm never. Mens Sana Monogr 2006;4:8-9.
  74. Singh AR, Singh SA. Notes on a few issues in the philosophy of psychiatry. Mens Sana Monogr 2009;7:128-83.
  75. Sheldon KM, Cheng C, Hilpert J. Understanding well-being and optimal functioning: Applying the multilevel personality in context (MPIC) model. Psychol Inq 2011;22:1-16.
  76. Shen K, Zeng Y. The association between resilience and survival among Chinese elderly. Demogr Res 2010;23:105-16.
  77. Slater E, Roth M. Introduction. The foundations of Psychiatry. In: Mayer-Gross Slater and Roth Clinical Psychiatry. 3 rd ed. London: Bailliere Tindall; 1986. p. 1-32.
  78. Stein DJ. Positive mental health: A note of caution. World Psychiatry 2012;11:107-9.
  79. Steptoe A, Wardle J. Positive affect and biological function in everyday life. Neurobiol Aging 2005;26 Suppl 1:108-12.
  80. Stewart DE, Yuen T. A systematic review of resilience in the physically ill. Psychosomatics 2011;52:199-209.
  81. Strawbridge WJ, Wallhagen MI, Cohen RD. Successful aging and well-being: Self-rated compared with Rowe and Kahn. Gerontologist 2002;42:727-33.
  82. Takala T. What is wrong with global bioethics? On the limitations of the four principles approach. Camb Q Healthc Ethics 2001;10:72-7.
  83. Tassano F. The Power of Life or Death. Medical Coercion and the Euthanasia Debate. London: Duckworth; 1995. Oxford: Oxford Forum; 1999.
  84. Tomás JM, Sancho P, Melendez JC, Mayordomo T. Resilience and coping as predictors of general well-being in the elderly: A structural equation modeling approach. Aging Ment Health 2012;16:317-26.
  85. Uchino BN. Social support and health: A review of physiological processes potentially underlying links to disease outcomes. J Behav Med 2006;29:377-87.
  86. Umberson D, Crosnoe R, Reczek C. Social relationships and health behavior across life course. Annu Rev Sociol 2010;36:139-57.
  87. Umberson D, Montez JK. Social relationships and health: A flashpoint for health policy. J Health Soc Behav 2010;1 Suppl: S54-66.
  88. Vahia IV, Depp CA, Palmer BW, Fellows I, Golshan S, Thompson W, et al. Correlates of spirituality in older women. Aging Ment Health 2011;15:97-102.
  89. Vance DE, Brennan M, Enah C, Smith GL, Kaur J. Religion, spirituality, and older adults with HIV: Critical personal and social resources for an aging epidemic. Clin Interv Aging 2011;6:101-9.
  90. Vaillant GE. The neuroendocrine system and stress, emotions, thoughts and feelings. Mens Sana Monogr 2011;9:113-28.
  91. Vaillant GE. Positive mental health: Is there a cross-cultural definition? World Psychiatry 2012;11:93-9.
  92. von Känel R, Mausbach BT, Mills PJ, Dimsdale JE, Patterson TL, Ancoli-Israel S, et al. Longitudinal relationship of low leisure satisfaction but not depressive symptoms with systemic low-grade inflammation in dementia caregivers. J Gerontol B Psychol Sci Soc Sci 2014;69:397-407.
  93. Westra AE, Willems DL, Smit BJ. Communicating with Muslim parents: "The Four Principles" are not as culturally neutral as suggested. Eur J Pediatr 2009;168:1383-7.
  94. Witter RA, Stock WA, Okun MA, Haring MJ. Religion and subjective well-being in adulthood: A quantitative synthesis. Rev Relig Res 1985;26:332-42.
  95. Zeng Y, Shen K. Resilience significantly contributes to exceptional longevity. Curr Gerontol Geriatr Res 2010;2010:525693.

Field of Psychiatry: Current Trends and Future Directions: An Indian Perspective

Kishore P. Dave (p108-117)


  1. Chaudhari LN, Deep S, Mridula N. Mental Health Care Bill 2013: A step leading to exclusion of psychiatry from mainstream medicine? Ind. J Psychiatry 2014;56:321.
  2. David S., Roger S. Oxford Handbook of psychiatry 3rd Edi 2013:18,30
  3. Heinz K. Are psychiatrists an endangered species? World psychiatry 2010,9(1);21
  4. Henry A. Psychiatry's future is here. Here are six trends that will affect your practice, Current psychiatry 2009:8:2.
  5. Sadock BJ, Sadock VA, Pedro R. Kaplan and Sadock's Synopsis of psychiatry: Behavioral Sciences/Clinical Psychiatry. 11 th Ed. 2015;3.
  6. Singh AR. The task before psychiatry today Redux:SPSPIR, Mens Sana Monographs 2014;12:35.

Task before Indian Psychiatry Today: Commentary

Avinash De Sousa (p118-132)


  1. Bhugra D. Mad Tales from Bollywood: Portrayal of Mental Illness Mental Illness in Conventional Hindi Cinema. Psychology Press; 2006.
  2. Brooks SJ, Stein DJ. A systematic review of the neural bases of psychotherapy for anxiety and related disorders. Dialogues Clin Neurosci 2015;17:261-79.
  3. Caplan G. An Approach to Community Mental Health. Vol. 3. Routledge Publishers; 2013.
  4. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS; Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, et al. Grand challenges in global mental health. Nature 2011;475:27-30.
  5. Ganju V. The mental health system in India. History, current system, and prospects. Int J Law Psychiatry 2000;23:393-402.
  6. Henderson C, Evans-Lacko S, Thornicroft G. Mental illness stigma, help seeking, and public health programs. Am J Public Health 2013;103:777-80.
  7. Huhn M, Tardy M, Spineli LM, Kissling W, Förstl H, Pitschel-Walz G, et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: A systematic overview of meta-analyses. JAMA Psychiatry 2014;71:706-15.
  8. Ingleby D. Critical Psychiatry: The Politics of Mental Health. Free Press; 2004.
  9. Lambert M. What we have learnt from a decade of research aimed at enhancing the outcome of psychotherapy research in primary care. Psychother Res 2007;17:1-14.
  10. Lépine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat 2011;7 Suppl 1:3-7.
  11. Math SB, Chandrashekar CR, Bhugra D. Psychiatric epidemiology in India. Indian J Med Res 2007;126:183-92.
  12. Mullan F. Doctors for the world: Indian physician emigration. Health Aff (Millwood) 2006;25:380-93.
  13. Nishtar S. Public - Private 'partnerships' in health - A global call to action. Health Res Policy Syst 2004;2:5.
  14. Norcross J. Psychotherapy Relationships that Work: Therapist Contributions and Responsiveness to Patients. Oxford University Press; 2002.
  15. Oyebode F. Sim's Symptoms in the Mind. 5 th ed. Saunders-Elsevier Publishers; 2015.
  16. Rao K. Lessons learnt in mental health and psychosocial care in India after disasters. Int Rev Psychiatry 2006;18:547-52.
  17. Richter J. Public private partnerships for health: A trend with no alternatives. Development 2004;47:43-8.
  18. Shanafelt TD, Boone SL, Dyrbye LN, Oreskovich MR, Tan L, West CP, et al. The medical marriage: A national survey of the spouses/partners of US physicians. Mayo Clin Proc 2013;88:216-25.
  19. Singh A, Singh S. Psychiatrists and clinical psychologists. Mens Sana Monogr 2006;4:10-3.
  20. Singh AR. The task before psychiatry today Redux: STSPIR. Mens Sana Monogr 2014;12:35-70.
  21. Singh AR. Blueprint for an Indian nobel laureate in psychiatry. Mens Sana Monogr 2015;13:187-207.
  22. Trzepacz PT, Baker RW. The Psychiatric Mental Status Examination. Oxford University Press; 1993.
  23. World Health Organization. Mental Health Report. Mental Health: New Understanding, New Hope. WHO; 2001.
  24. Yellowlees P, Chan S. Mobile mental health care - an opportunity for India. Indian J Med Res 2015;142:359-61.

Out of Flatland: The Role of the Notion of a Worldview in the Science of Well-being

Danilo Garcia* and Patricia Rosenberg (p133-140)


  1. Abbott EA. Flatland: A Romance in Many Dimensions. New York: Dover; 1884.
  2. Aknin LB, Barrington-Leigh CP, Dunn EW, Helliwell JF, Burns J, Biswas-Diener R, et al. Prosocial spending and well-being: Cross-cultural evidence for a psychological universal. J Pers Soc Psychol 2013;104:635-52.
  3. Cloninger RC. Feeling Good: The Science of Well-Being. New York: Oxford University Press; 2004.
  4. Cloninger CR. The science of well-being: An integrated approach to mental health and its disorders. World Psychiatry 2006;5:71-6.
  5. Cloninger CR. Spirituality and the science of feeling good. South Med J 2007;100:740-3.
  6. Cloninger CR. Science of Well-Being: How to be Healthy, Happy, and Fulfilled in the Face of Current World Challenges. Lecture Conducted at the University of Gothenburg, Gothenburg, Sweden; March, 2012.
  7. Cloninger CR. What makes people healthy, happy, and fulfilled in the face of current world challenges? Mens Sana Monogr 2013;11:16-24.
  8. Cloninger CR. Degeneracy of categorical disease paradigms. Philos Psychiatr Psychol 2013;20:275-9.
  9. Cloninger CR. The importance of ternary awareness for overcoming the inadequacies of contemporary psychiatry. Rev Psyquiatr Clin 2013;40:110-113.
  10. Cloninger CR, Zohar AH. Personality and the perception of health and happiness. J Affect Disord 2011;128:24-32.
  11. Cohen GL, Aronson J, Steele CM. When beliefs yield to evidence: Reducing biased evaluation by affirming the self. Pers Soc Psychol Bull 2000;26:1151-64.
  12. Dawkins R. The Extended Phenotype - The Long Reach of the Gene. New York: Oxford University Press; 1982.
  13. Garcia D, Anckarsäter H, Kjell ON, Archer T, Rosenberg P, Cloninger CR, et al. Agentic, communal, and spiritual traits are related to the semantic representation of written narratives of positive and negative life events. Psychol Well Being 2015;5:1-20.
  14. Gazzaniga MS. Who's in Charge? Free Will and the Science of the Brain. New York: HarperCollins Publishers; 2011.
  15. Greenberg J, Pyszczynski T, Solomon S, Rosenblatt A, Veeder M, Kirkland S, et al. Evidence for terror management II: The effects of mortality salience on reactions to those who threaten or bolster the cultural worldviews. J Pers Soc Psychol 1990;58:308-18.
  16. Haidt J. The Happiness Hypothesis: Finding Modern Truth in Ancient Wisdom. New York: Basic Books; 2006.
  17. Hart J, Shaver PR, Goldenberg JL. Attachment, self-esteem, worldviews, and terror management: Evidence for a tripartite security system. J Pers Soc Psychol 2005;88:999-1013.
  18. Josefsson K, Jokela M, Cloninger CR, Hintsanen M, Salo J, Hintsa T, et al. Maturity and change in personality: Developmental trends of temperament and character in adulthood. Dev Psychopathol 2013;25:713-27.
  19. Kahneman D. Thinking, Fast and Slow. New York: Allen Lane; 2011.
  20. Koltko-Rivera ME. The psychology of worldviews. Rev Gen Psychol 2004;1:3-58.
  21. McAdams DP. Personal narratives and the life story. In: John O, Robins R, Pervin LA, editors. Handbook of Personality: Theory and Research. 3 rd ed. New York: Guilford Press; 2008. p. 241-61.
  22. Myers DG, Diener E. Who is happy? Psychol Sci 1995;1:10-8.
  23. Nilsson A. A non-reductive science of personality, character, and well-being must take the person's worldview into account. Front Psychol 2014;5:961.
  24. Pennebaker JW. The Secret Life of Pronouns. What Our Words Say About Us. New York: Bloomsbury Press; 2011.
  25. Shweder RA, Much NC, Mahapatra M, Park L. The 'Big Three' of morality (autonomy, community, divinity) and the 'Big Three' explanations of suffering. In: Brandt M, Rozin P, editors. Morality and Health. New York: Routledge; 1997. p. 119-72.

The Problem of Dualism in Modern Western Medicine

Mathew H. Gendle (p141-151)


  1. Baker M, Menken M. Time to abandon the term mental illness. Br Med J 2001;322:937.
  2. Beauregard M, O'Leary D. The Spiritual Brain: A Neuroscientist's Case for the Existence of the Soul. New York: Harper One; 2007.
  3. Blackmore S. Deepak Chopra may be Wealthy, but even he knows that's all an Illusion. The Guardian; 7 May, 2012. Available from : http://www.theguardian.com/commentisfree/belief/2012/may/07/deepak-chopra-wealthy-knows-illusion. [Last accessed on 2016 Feb 11].
  4. Chopra D. Medicine's great divide-the view from the alternative side. Virtual Mentor 2011;13:394-8.
  5. Clayton P. Mind and Emergence: From Quantum to Consciousness. New York: Oxford University Press; 2004.
  6. Gold J. Cartesian dualism and the current crisis in medicine - a plea for a philosophical approach: Discussion paper. J R Soc Med 1985;78:663-6.
  7. Hameroff S, Penrose R. Consciousness in the universe: A review of the 'Orch OR' theory. Phys Life Rev 2014;11:39-78.
  8. Jain S, Daubenmier J, Muehsam D, Rapgay L, Chopra D. Indo-tibetan philosophical and medical systems: Perspectives on the biofield. Glob Adv Health Med 2015;4  Suppl:16-24.
  9. Joubert C. Medicine and mind-body dualism: A reply to Mehta's critique. Mens Sana Monogr 2014;12:104-26.
  10. Kendler KS. Toward a philosophical structure for psychiatry. Am J Psychiatry 2005;162:433-40.
  11. Levine J. Materialism and qualia: The explanatory gap. Pac Philos Q 1983;64:354-61.
  12. López-Ibor JJ, López-Ibor MI. Paving the way for new research strategies in mental disorders. First part: The recurring crisis of psychiatry. Actas Esp Psiquiatr 2013;41:33-43.
  13. Mehta N. Mind-body dualism: A critique from a health perspective. Mens Sana Monogr 2011;9:202-9.
  14. Peterson GR. Species of emergence. Zygon 2006;41:689-712.
  15. Sandberg LS, Busch FN. Psychotherapy and pharmacotherapy: A contemporary perspective. Psychodyn Psychiatry 2012;40:505-32.
  16. Searle JR. Consciousness. Annu Rev Neurosci 2000;23:557-78.
  17. Shelton W. A new look at medicine and the mind-body problem: Can Dewey's pragmatism help medicine connect with its mission? Perspect Biol Med 2013;56:422-41.
  18. Singer W. Consciousness and the structure of neuronal representations. Philos Trans R Soc Lond B Biol Sci 1998;353:1829-40.
  19. Singh AR, Singh SA. Brain-mind dyad, human experience, the consciousness tetrad and lattice of mental operations: And further, the need to integrate knowledge from diverse disciplines. Mens Sana Monogr 2011;9:6-41.
  20. Sullivan M. In what sense is contemporary medicine dualistic? Cult Med Psychiatry 1986;10:331-50.
  21. Switankowsky I. Dualism and its importance for medicine. Theor Med Bioeth 2000;21:567-80.
  22. Tononi G, Koch C. The neural correlates of consciousness: An update. Ann N Y Acad Sci 2008;1124:239-61.
  23. Wade D. Why physical medicine, physical disability and physical rehabilitation? We should abandon Cartesian dualism. Clin Rehabil 2006;20:185-90.

End-of-Life Care and Psychiatry: Current Trends and Future Directions in India

Jayita K. Deodhar (p152-170)


  1. Barazzetti G, Borreani C, Miccinesi G, Toscani F. What "best practice" could be in Palliative Care: An analysis of statements on practice and ethics expressed by the main health organizations. BMC Palliat Care 2010;9:1.
  2. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 6 th ed. New York: Oxford University Press; 2009.
  3. Bloomer M, Tan H, Lee S. End of life care - The importance of advance care planning. Aust Fam Physician 2010;39:734-7.
  4. Breitbart W, Rosenfeld B, Gibson C, Pessin H, Poppito S, Nelson C, et al. Meaning-centered group psychotherapy for patients with advanced cancer: A pilot randomized controlled trial. Psychooncology 2010;19:21-8.
  5. Chakravarty A, Kapoor P. Concepts and debates in end-of-life care. Indian J Med Ethics 2012;9:202-6.
  6. Chapman L, Ellershaw J. Care in the last hours and days of life. Medicine 2011;39:674-7.
  7. Chochinov HM. Psychiatry and terminal illness. Can J Psychiatry 2000;45:143-50.
  8. Chochinov HM, Hack T, Hassard T, Kristjanson LJ, McClement S, Harlos M. Dignity therapy: A novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol 2005;23:5520-5.
  9. Connors AF, Dawson NV, Desbiens NA, Fulkerson WJ, Goldman L, Knaus WA, et al. A Controlled trial to improve care for seriously III hospitalized patients: The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995;274:1591-8.
  10. Dzingina MD, Higginson IJ. Public health and palliative care in 2015. Clin Geriatr Med 2015;31:253-63.
  11. Fairman N, Irwin SA. Palliative care psychiatry: Update on an emerging dimension of psychiatric practice. Curr Psychiatry Rep 2013;15:374.
  12. Gaertner J, Frechen S, Sladek M, Ostgathe C, Voltz R. Palliative care consultation service and palliative care unit: Why do we need both? Oncologist 2012;17:428-35.
  13. Gibbins J, McCoubrie R, Forbes K. Why are newly qualified doctors unprepared to care for patients at the end of life? Med Educ 2011;45:389-99.
  14. Gupta V, Kumar S, Shukla A, Kumar S, Kumar S. End-of-life care of terminally ill geriatric cancer patients in Northern India. Natl Med J India 2007;20:74-7.
  15. Ingle GK, Nath A. Geriatric health in India: Concerns and solutions. Indian J Community Med 2008;33:214-8.
  16. Irwin SA, Montross LP, Bhat RG, Nelesen RA, von Gunten CF. Psychiatry resident education in palliative care: Opportunities, desired training, and outcomes of a targeted educational intervention. Psychosomatics 2011;52:530-6.
  17. Kissane DW, McKenzie M, Bloch S, Moskowitz C, McKenzie DP, O'Neill I. Family focused grief therapy: A randomized, controlled trial in palliative care and bereavement. Am J Psychiatry 2006;163:1208-18.
  18. Kubler-Ross E. On Death and Dying. New York: Macmillan; 1969.
  19. Kübler-Ross E, Wessler S, Avioli LV. On death and dying. JAMA 1972;221:174-9.
  20. Kulkarni P, Kulkarni P, Anavkar V, Ghooi R. Preference of the place of death among people of pune. Indian J Palliat Care 2014;20:101-6.
  21. Kumar S. Models of delivering palliative and end-of-life care in India. Curr Opin Support Palliat Care 2013;7:216-22.
  22. Lawrence V, Samsi K, Murray J, Harari D, Banerjee S. Dying well with dementia: Qualitative examination of end-of-life care. Br J Psychiatry 2011;199:417-22.
  23. Luckett T, Phillips J, Agar M, Virdun C, Green A, Davidson PM. Elements of effective palliative care models: A rapid review. BMC Health Serv Res 2014;14:136.
  24. Luta X, Maessen M, Egger M, Stuck AE, Goodman D, Clough-Gorr KM. Measuring intensity of end of life care: A systematic review. PLoS One 2015;10:e0123764.
  25. Macaden SC, Salins N, Muckaden M, Kulkarni P, Joad A, Nirabhawane V, et al. End of life care policy for the dying: Consensus position statement of Indian Association of Palliative Care. Indian J Palliat Care 2014;20:171-81.
  26. Macaden SC. Moving toward a national policy on palliative and end of life care. Indian J Palliat Care 2011;17  Suppl:S42-4.
  27. Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal attainment, and distress at the end of life: Predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 2010;28:1203-8.
  28. Mani RK. Limitation of life support in the ICU. Indian J Crit Care Med 2003;7:112-7.
  29. McCabe MS, Storm C. When doctors and patients disagree about medical futility. J Oncol Pract 2008;4:207-9.
  30. McCormack R, Fléchais R. The role of psychiatrists and mental disorder in assisted dying practices around the world: A review of the legislation and official reports. Psychosomatics 2012;53:319-26.
  31. Myatra SN, Divatia J, Tandekar A, Khanvalkar V. An audit of end of life practices in an Indian Cancer Hospital ICU. Intensive Care Med 2010;36:S386.
  32. Myatra SN, Salins N, Iyer S, Macaden SC, Divatia JV, Muckaden M, et al. End-of-life care policy: An integrated care plan for the dying: A Joint Position Statement of the Indian Society of Critical Care Medicine (ISCCM) and the Indian Association of Palliative Care (IAPC). Indian J Crit Care Med 2014;18:615-35.
  33. National Accreditation Board for Hospitals Standards. 4 th ed. 2015.
  34. National Institute for Health and Clinical Excellence. CG42 Dementia: NICE Guideline. 2006 Notes. 2006. p. 1-56.
  35. Olausson J, Ferrell BR. Care of the body after death. Clin J Oncol Nurs 2013;17:647-51.
  36. Phillips JL, Halcomb EJ, Davidson PM. End-of-life care pathways in acute and hospice care: An integrative review. J Pain Symptom Manage 2011;41:940-55.
  37. Quenot JP, Rigaud JP, Prin S, Barbar S, Pavon A, Hamet M, et al. Impact of an intensive communication strategy on end-of-life practices in the intensive care unit. Intensive Care Med 2012;38:145-52.
  38. Raijmakers NJ, van Zuylen L, Costantini M, Caraceni A, Clark JB, De Simone G, et al. Issues and needs in end-of-life decision making: An international modified Delphi study. Palliat Med 2012;26:947-53.
  39. Sampson EL, Burns A, Richards M. Improving end-of-life care for people with dementia. Br J Psychiatry 2011;199:357-9.
  40. Sarin A. On psychiatric wills and the Ulysses clause: The advance directive in psychiatry. Indian J Psychiatry 2012;54:206-7.
  41. Shaji KS. Dementia care in developing countries: The road ahead. Indian J Psychiatry 2009;51 Suppl 1:S5-7.
  42. Sharma K. Burden of non communicable diseases in India: Setting priority for action. Int J Med Sci Public Health 2013;2:7-11.
  43. Sharma P, Charak R, Sharma V. Contemporary perspectives on spirituality and mental health. Indian J Psychol Med 2009;31:16-23.
  44. Shaw KL, Clifford C, Thomas K, Meehan H. Review: Improving end-of-life care: A critical review of the gold standards framework in primary care. Palliat Med 2010;24:317-29.
  45. Shreves A, Marcolini E. End of life/palliative care/ethics. Emerg Med Clin North Am 2014;32:955-74.
  46. Singer PA, Bowman KW. Quality end-of-life care: A global perspective. BMC Palliat Care 2002;1:4.
  47. Singh AR, Singh SA. Notes on a few issues in the philosophy of psychiatry. Mens Sana Monogr 2009;7:128-83.
  48. Smith R. A good death. An important aim for health services and for us all. BMJ 2000;320:129-30.
  49. Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T. Association between advance directives and quality of end-of-life care: A national study. J Am Geriatr Soc 2007;55:189-94.
  50. The Quality of Death Index 2015 - Ranking Palliative Care Across the World. A Report by the Economist Intelligence Unit, October, 2015.
  51. van Soest-Poortvliet MC, van der Steen JT, de Vet HC, Hertogh CM, Deliens L, Onwuteaka-Philipsen BD. Comfort goal of care and end-of-life outcomes in dementia: A prospective study. Palliat Med 2015;29:538-46.
  52. World Health Organization. World Health Statistics 2012. Vol. 27. World Health Organization; 2012. p. 171.

Lessons of Being a Patient-- Personal Thoughts about Psycho-oncology in India

Rangaswamy Srinivasa Murthy (p171-186)


  1. Abhishekh HA, Balaji AL, Mehta RM. Depression in lung cancer patients. Indian J Psychiatry 2014;56:307.
  2. Ayyagiri S, Kalia S, Srinivasa Murthy R. Psychosocial aspects of cancer. Bull Radiat Oncol 1979;1:30-4.
  3. Bapsy PP. The dream for life. Bangalore: Ambrosia Life Sciences; 2011.
  4. Bhat V, Bhat N. My Cancer Is Me. New Delhi: Hay House; 2013.
  5. Barthakur M. A Cancer Survivor-Struggle and Success. Delhi: BR Publishing; 2008
  6. Chaturvedi SK. Psychiatric oncology: Cancer in mind. Indian J Psychiatry 2012;54:111-8.
  7. HCG SelfV-Survivor Stories. Available from: https://www.facebook.com/healthcareglobalenterprises/photos/pb.188201678005488.-2207520000.1424510993./ 302185033273818/?type=1&theater. [Last accessed on 2015 Feb 21].
  8. Holland JC, Lewis S. The Human Side of Cancer-Living with Hope, Coping with Uncertainty. New York: Harper; 2001.
  9. Holland JC, Bretbart WS, Jacobson PB, Lederberg HS, Loscalzo MJ, McCorkle R. Psycho-Oncology. 2 nd ed. New York: Oxford University Press; 2010.
  10. Kumar A. The Joy of Cancer. New Delhi: Rupa; 2002.
  11. Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS, et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol 2014;15:e205-12.
  12. Moorjani A. Dying to Be Me-My Journey from Cancer, to Near Death, to True Healing. New Delhi: Hay House; 2012.
  13. Mukherjee S. The Emperor of All Maladies: A Biography of Cancer. London: Fourth Estate; 2011.
  14. Nayak V. Enduring Cancer-Stories of Hope. Delhi: Byword Books; 2011.
  15. Scientific American. Breaking Bad Habits (Finding Happiness through Change). Scientific American; 2014.
  16. Singh Y. The Test of My Life. Noida: Random House; 2013.
  17. Srivatsava R. Tell Me the Truth-Conversations with my Patients About Cancer, Life and Death. New York: Harper; 2014.
  18. Vattam K. Joy of Conquering Cancer: A Spiritual Dimension. Bengaluru: Darpan Books; 2014.

In Search of Rationality in Human Longevity and Immortality

Gopal C. Bhar (p187-213)


  1. Aledo JC, Li Y, de Magalhães JP, Ruíz-Camacho M, Pérez-Claros JA. Mitochondrially encoded methionine is inversely related to longevity in mammals. Aging Cell 2011;10:198-207.
  2. Balaji PA, Varne SR, Ali SS. Physiological effects of yogic practices and transcendental meditation in health and disease. N Am J Med Sci 2012;4:442-8.
  3. Barzilai N, Bartke A. Biological approaches to mechanistically understand the healthy life span extension achieved by calorie restriction and modulation of hormones (Conference Paper). J Gerontol A Biol Sci Med Sci 2009;64:187-91.
  4. Bengtson VL, Gans D, Putney N, Silverstein M, editors. Handbook of Theories of Aging. New York: Springer; 2009.
  5. Bhar GC. Roles of brain and heart in life management. Indian Sci Cruiser 2012;26:47-54.
  6. Bhar GC. The Scientific Basis of Habit: Spirituality in the Light of Neuroplasticity; Vedanta Kesari 2014;101:229-34.
  7. Bhar GC. In search of possible physical laws in spirituality. Prabuddha Bharata 2015;120:648-51, 710-9.
  8. Bortz HW, Stickrod R. The roadmap to 100: The Breakthrough Science of Living a Long and Healthy Life. New York: Palgrave McMillan; 2010.
  9. Bose AC. The Call of the Vedas. Mumbai: Bharatiya Vidya Bhavan; 1999a. p. 279.
  10. Bose AC. The Call of the Vedas. Mumbai: Bharatiya Vidya Bhavan; 1999b. p. 128.
  11. Carrel A. Man, the Unknown. Halycon House; 1938
  12. Carrillo AE, Flouris AD. Caloric restriction and longevity: effects of reduced body temperature. Ageing Res Rev 2011;10:153-62.
  13. Chittester J. The Gift of Years: Growing Older Gracefully. Bluebridge; 2008.
  14. Dalby P. Is there a process of spiritual change or development associated with ageing? A critical review of research. Aging Ment Health 2006;10:4-12.
  15. Davies M, Murthy B. Chanakya's Niti-Sastra. CreateSpace Independent Publishing Platform; 2012.
  16. Dean W. What You Should Know About DHEA. Life Enhancement Magazine; December, 2013. Available from: http://www.life-enhancement.com/magazine/December/2013. [Last accessed on 2016 Feb 26].
  17. Donovan S, Murphy M, Taylor E. The Physical and Psychological Effects of Meditation- A Review of Contemporary Research. Institute of Noetic Sciences; 1997.
  18. Eddington AS. The Nature of the Physical World. New York: Macmillan; 1928.
  19. Editor. Senescence and spiritual life. Prabuddha Bharat 1973;78:363-8.
  20. Einstein A. Interview: Talk with New York Times March 12, 1944. As Quoted in Life Magazine; 2 May, 1955.
  21. Fahy GM, West MD, Stephen C, Harries SB. The Future of Ageing-Pathways to Human Life Extension. Springer; 2010. p. 410-1.
  22. Farrant A. Longevity and the Good Life. Basingstoke: Palgrave McMillan; 2010.
  23. Ferrucci L, Simonsick EM. A little exercise. J Gerontol A Biol Sci Med Sci 2006;61:1154-6.
  24. Flatt JD, Hughes TF. Participation in social activities in later life: Does enjoyment have important implications for cognitive health. Aging Health 2013;9:149-58.
  25. Franklin NC, Tate CA. Lifestyle and successful aging: An overview. Am J Lifestyle Med 2009;3:6-11.
  26. Freitas AA, de Magalhães JP. A review and appraisal of the DNA damage theory of ageing. Mutat Res 2011;728:12-22.
  27. Gao H, Huang HZ, Zhu SP, Li YF, Yuan RA. Modified nonlinear damage accumulation model for fatigue life prediction considering load interaction effects. ScientificWorldJournal 2014;2014:164378. Available from: http://www.d ×.doi.org/10.1155/2014/164378. [Last accessed on 2016 Feb 21].
  28. Glade MJ. Oxidative stress and cognitive longevity. Nutrition 2010;26:595-603.
  29. Sir Huxley J. Evolution: The Modern Synthesis. John Wiley and Sons; 1974.
  30. Iyengar BK. Light on the Yoga Sutras of Patanjali. Thorsons; 2002.
  31. Kirkwood TB. Why can't we live forever? Sci Am 2010;303:42-9.
  32. Kirkwood TB. Systems biology of ageing and longevity. Philos Trans R Soc Lond B Biol Sci 2011;366:64-70.
  33. Lavretsky H. Spirituality and aging. Aging Health 2010;6:749-69.
  34. de Magalhães JP, Church GM. Cells discover fire: employing reactive oxygen species in development and consequences for aging. Exp Gerontol 2006;41:1-10.
  35. McNaughton SA, Bates CJ, Mishra GD. Diet quality is associated with all-cause mortality in adults aged 65 years and older. J Nutr 2012;142:320-5.
  36. Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci 2011;66:202-13.
  37. MIPPA, Madrid International Plan of Action on Ageing; 2002. Available from: http://www.ods-dds-ny.un.org/doc/UNDOC/GEN/N02/297/53/PDF/No239753.pdt? [Last accessed on 2016 Feb 21].
  38. (De) Megalhaise JP. Anti-Aging Medicine; Available from: http://www.senescence.info/antiaging_science.html. [Last accessed 2016 Feb 21].
  39. Miskotnykh VV, Khodasevich LS, Mel'tser VL. Effect of physical activity on age involution of functional abilities of humans. Adv Gerontol 2012;25:648-53.
  40. Mitteldorf J. Aging is not a process of wear and tear. Rejuvenation Res 2010;13:322-6.
  41. Nara T. Japanese Approach to the Elderly. Prabuddha Bharat; April, 2009.
  42. Parkar SR. Elderly mental health: needs. Mens Sana Monogr 2015;13:91-9.
  43. Powers SK, Lennon SL. Analysis of cellular responses to free radicals: focus on exercise and skeletal muscle. Proc Nutr Soc 1999;58:1025-33.
  44. PHARMA; 2007. Available from: http://www.innovation.org/drug_discovery/objects/pdf/RD_Brochure.pdf. [Last accessed on 2016 Feb 21].
  45. Radhakrishnan S, editor. The Principal Upanishads. New York: Harper and Brown; 1953. p. 593-648. Available from: http://www.hinduwebsite.com/upaindex.asp. [Last accessed 2016 Feb 21].
  46. Robson D. Growth Hormone: What Is It and What Does It Do - An Expert's View! Available from: http://www.bodybuilding.com/fun/ali_amini_gh_interview.htm. [Last accessed on 2016 Feb 21; Last updated on Jun 2015 17].
  47. Rockenfeller P, Madeo F. Ageing and eating. Biochim Biophys Acta 2010;1803:499-506.
  48. Siddiqi AF. Age likes some years: A case study for ages more prone to death. Scientometrics 2006;69:315-32.
  49. Singh AR. Modern medicine: Towards prevention, cure, well-being and longevity. Mens Sana Monogr 2010;8:17-29.
  50. Strulick H, Vollmer S. Long-Run Trends of Human Aging and Longevity in Program on the Global Demography of Aging. Working Paper Series PGDA Working Paper No. 73; August, 2011. Available from: http://www.hsph.harvard.edu/pgda/working.htm. [Last accessed on 2016 Feb 21].
  51. Stevenson I. Children Who Remember Previous Lives: A Question of Reincarnation. Revised Edition. McFarland; 2000.
  52. Stibich 2014. The Okinawans - Japanese Longevity and Healthy Aging; 2014. Available from: http://www.longevity.about.com/od/healthyagingandlongevity/a/okinawan_aging.htm. [Last accessed on 2016 Feb 21].
  53. Swami Ranganathananda. The Messages of Brihadaranyaka Upanishad. Kolkata: Advaita Ashram;2005.
  54. Swami Vivekananda. The Complete Works of Swami Vivekananda. Vol. 1. Raja-Yoga, Vol. 2. Jnana-Yoga. Kolkata: Kolkata Advaita Ashrama; 2000. Available from: http://www.en.wikisource.org/wiki/The_Complete_Works_of_Swami_Vivekananda/Volume_2/Jnana-Yoga/God_in_Everything . [Last accessed on 2016 Feb 21].
  55. Swami Vivekananda. The Timeless Thoughts of Swami Vivekananda. Birister Sharma; 31 August, 2015. Available from: http://www.TheCompleteWorksofSwamiVivekananda/Volume2/PracticalVedantaandotherlecture/PracticalVedanta:PartII . [Last accessed on 2016 Feb 21].
  56. Swami Yatiswarananda. Meditation and Spiritual Life. Kolkata: Advaita Ashrama; 2007
  57. Terman FE. Electronic and Radio Engineering. McGraw-Hill; 1957.
  58. Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003;299:1346-51.
  59. Underhill E. Mysticism. CreateSpace Independent Publishing Platform; 2011.
  60. Vaillant GE. Positive emotions, spirituality and the practice of psychiatry. Mens Sana Monogr 2008;6:48-62.
  61. Weiler R, Stamatakis E, Blair S. Should health policy focus on physical activity rather than obesity? Yes. BMJ 2010;340:c2603.
  62. Whiteman H. 'Fasting-Mimicking Diet' May Promote Health and Longevity. MNT Knowledge Center; 21 June, 2015. Available from http://www.medicalnewstoday.com/articles/295647.php [Last accessed on 2016 Feb 21].
  63. Defeng WU, Cederbaum AI. Alcohol, Oxidative Stress, and Free Radical Damage. NIAAA: Understanding the Impact of Alcohol on Human Health and Well-Being, Prepared; October 2004. Available from: http://www.pubs.niaaa.nih.gov/publications/arh27-4/277-284.htm. [Last accessed on 2016 Feb 21].

What Music Means To Me

Ajai R. Singh (p229-239)


  1. Longfellow HW. A Psalm of Life. Poetry Foundation. Available from: http://www.poetryfoundation.org/poems-and-poets/poems/detail/44644. [Last accessed on 2015 Oct 08].
  2. Shelley PB. To a Skylark. Poetry Foundation. Available from: http://www.poetryfoundation.org/poems-and-poets/poems/detail/45146. [Last accessed on 2015 Oct 08].
  3. Singh AR. YouTube Channel. Available from: http://www.youtube.com/channel/UCp7rPVl3YtzOs8VYu7QdecQ. [Last accessed on 2016 Apr 08].
  4. YouTube: Bachpan Ke Din Bhulana Na Dena. Lyrics: Shakeel Badayuni. Singers Lata Mangeshkar & Shamshad Begum. Music Naushad, Film Deedar; 1951. Available from: http://www.youtube.com/watch?v=NTNzuUGMmUY. [Last accessed on 2015 Oct 08].
  5. YouTube. Hain Sabse Madhur Woh Geet. Lyrics: Shailendra. Singer Talat Mahmood. Music Shankar Jaikishan. Film Patita, 1953, Bombay Talkies. Available from: http://www.youtube.com/watch?v=Woq2e_3zSsU. [Last accessed on 2015 Oct 08].
  6. YouTube. Ruk Na Sako to Jao. Singer Aroon Kumar. Music Saraswati Devi and Ram Chandra Pal. Film Bandhan, 1939, Bombay Talkies. Available from: http://www.youtube.com/watch?v=8QLgg6eQ-Vo. [Last accessed on 2015 Oct 08].


Print this article  Email this article
    Similar in PUBMED
    Article in PDF (293 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 Article Access Statistics
    PDF Downloaded20    
    Comments [Add]    

Recommend this journal